If migraine attacks recur regularly and interfere with everyday life, treatment with botulinum toxin type A may be one of the available therapeutic options. The procedure involves precise injections into selected points of the head, neck and nape — following medical eligibility assessment and the development of an individual treatment plan. The therapy is provided by Piotr Rak, MD, PhD, in Gdańsk.
Registration: Mon–Fri, 9:00 a.m.–5:00 p.m. Gdańsk, 15 Toruńska Street.
| What it is | injections of BTX-A into selected points of the head and neck |
| Who it is for | chronic migraine — following medical eligibility assessment |
| Initial effects | usually within a few days |
| Full effect | approximately 5–6 weeks |
| Duration of action | up to approximately 12 weeks; cyclical treatment |
| Doctor | Piotr Rak, MD, PhD |
| Price | see the price list |
The treatment involves administering small doses of botulinum toxin type A into precisely selected points around the forehead, temples, back of the head and nape. The injection pattern is always determined individually on the basis of the patient’s migraine history. The aim is to reduce muscle tension and limit the release of pain mediators from nerve endings — mechanisms that may be involved in the development of migraine attacks.
The toxin acts locally at the injection site. Systemic effects are minimal. This treatment has been evaluated in randomised clinical trials as one of the treatment options for chronic migraine in patients for whom other forms of therapy have not provided satisfactory improvement.
The treatment does not address the underlying cause of migraine. It may reduce the frequency and severity of attacks in patients with chronic migraine. The suitability and expected effectiveness of treatment in a particular case are assessed by the doctor during the eligibility consultation.
Botulinum toxin treatment for chronic migraine may be considered for people who:
Eligibility is always determined by the doctor after taking a medical history concerning the patient’s migraines, previous treatment and general health.
The doctor discusses the patient’s migraine history, previous treatment and expectations. The doctor assesses the indications and contraindications and prepares an injection plan.
A series of precise, small injections into selected points of the head, neck and nape. The scope of treatment is selected individually. The procedure is performed on an outpatient basis.
Initial effects may appear within a few days. The full therapeutic effect is assessed after approximately 5–6 weeks. The individual response time may vary.
The effects of the preparation usually last for up to approximately 12 weeks. Treatment is cyclical, and the next steps are determined by the doctor during a follow-up appointment.
Botulinum toxin is used in therapeutic doses for migraine treatment and acts locally. However, like every medical procedure, it is associated with a specific profile of adverse effects, which the doctor discusses before treatment. More common and temporary adverse effects include: pain or tenderness at the injection site, temporary headache or neck pain after the procedure, and swelling or bruising at the injection site. Less common effects include: drooping of the eyelid or eyebrow — usually temporary and lasting several weeks, facial asymmetry, general weakness or fatigue on the day of the procedure, and flu-like symptoms. Serious complications are rare when the correct technique is used by an experienced doctor. The full risk profile is discussed by the doctor during the eligibility consultation.
A complete assessment of contraindications is carried out during the medical consultation.
★★★★★ 5.0 · patient reviews on ZnanyLekarz
A surgeon providing botulinum toxin treatment for chronic migraine. He conducts eligibility consultations, develops individual injection plans and provides regular follow-up assessments of treatment results.
Piotr Rak, MD, PhD · eligibility consultation · cyclical treatment
Gdańsk, 15 Toruńska Street · Mon–Fri, 9:00 a.m.–5:00 p.m.
Botulinum toxin treatment has an established role in the treatment of chronic migraine and has been evaluated in randomised clinical trials. The toxin acts locally, and systemic effects are minimal. Possible and usually temporary adverse effects include pain at the injection site, temporary headache or neck pain after the procedure, drooping of the eyelid or eyebrow — ptosis, which is rare and temporary — asymmetry and swelling. The doctor discusses the full risk profile for each individual patient during the eligibility assessment.
Initial effects may appear within a few days of the procedure. The full therapeutic effect is most commonly assessed after approximately 5–6 weeks. The individual response time may vary, and the doctor monitors the results during follow-up appointments.
The effects of botulinum toxin usually last for up to approximately 12 weeks. Treatment is cyclical, with subsequent sessions usually performed every three months. The treatment plan is established and reviewed by the doctor during follow-up appointments.
No. Eligibility is determined by the doctor after taking a medical history and assessing the indications and contraindications. Treatment is considered mainly for chronic migraine when other treatment methods have not provided satisfactory improvement. There is a list of contraindications, including neuromuscular disorders and pregnancy, which the doctor assesses individually.
The treatment is cyclical. A series of three procedures performed approximately every three months is commonly used. The number of sessions and the further treatment plan are determined by the doctor on the basis of the results observed in the individual patient.
The procedure involves a series of small injections. Most patients describe it as well tolerated. Sensations vary between individuals, and the doctor selects the method of administration with the patient’s comfort in mind.
Botulinum toxin does not treat the underlying cause of migraine, and its effects are temporary. The aim of treatment is to reduce the frequency and severity of attacks, which may improve everyday functioning. The doctor discusses the effects and long-term treatment plan individually.
The current price list is available on the clinic’s website, or you can ask about the price when registering by telephone. The doctor discusses the cost and scope of treatment during the eligibility consultation. The price depends on the planned scope of injections.
A different indication: reduction of facial expression lines and relaxation of facial muscles.
Details →Diluted BTX-A administered intradermally to improve skin texture.
Details →Medical history, eligibility assessment and development of a treatment plan.
Details →Piotr Rak, MD, PhD · cyclical treatment · eligibility consultation
Gdańsk, 15 Toruńska Street · Mon–Fri, 9:00 a.m.–5:00 p.m. · tel. +48 600 006 913
The information on this page is provided for general educational purposes and does not replace a medical or neurological consultation. Botulinum toxin treatment for chronic migraine requires an individual medical eligibility assessment and an evaluation of the indications and contraindications. Treatment outcomes vary between patients and cannot be guaranteed in advance. Wyspa Medycyny Przyjaznej, 15 Toruńska Street, unit AU1, Gdańsk. Tel.: +48 600 006 913.